Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Supplement Claims For Autism Treatment Could Ring A Bell At FTC

This article was originally published in The Tan Sheet

Executive Summary

The firm that challenged Pursuit of Research’s claims and prompted a NAD review, NourishLife LLC, already incurred FTC enforcement about unsubstantiated claims that products treat childhood speech disorders.

Advertisement

Related Content

New York AG And FTC Target Prevagen Memory Claims
NAD Could Jog Cognitive Benefit Supplement Firm's Memory With FTC Call
Supplement Cognitive Claims Remain Online, But Closed Firm Off NAD Hook

Topics

Advertisement
UsernamePublicRestriction

Register

PS107728

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel